Mangafodipir as an Adjunct to FOLFOX6 Chemotherapy in Colon Cancer Stage Dukes' C
Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
The present feasibility study is designed to find out whether pre-treatment with the compound
mangafodipir lowers the frequency and severity of side effects during adjuvant chemotherapy
according to the FOLFOX6 regimen in patients operated upon colon cancer in stage Dukes' C.